Eli Lilly and Co (LLY)

pos +2.10
Today's Range: 85.00 - 85.73 | LLY Avg Daily Volume: 5,092,700
Last Update: 10/09/15 - 9:57 AM EDT
Volume: 621,845
YTD Performance: 21.42%
Open: $85.34
Previous Close: $83.77
52 Week Range: $60.58 - $92.85
Oustanding Shares: 1,108,540,541
Market Cap: 93,106,320,039
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 0 0 0 1
Hold 5 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.83 1.83 1.83 1.71
Latest Dividend: 0.50
Latest Dividend Yield: 2.38%
Dividend Ex-Date: 08/12/15
Price Earnings Ratio: 43.52
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
43.52 43.60 25.13
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.99% 28.40% 64.97%
Revenue -15.10 -0.19 -0.07
Net Income -49.00 -0.45 -0.18
EPS -48.50 -0.43 -0.17
Earnings for LLY:
Revenue 19.62B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.75 $0.76 $3.28 $3.62
Number of Analysts 9 7 12 12
High Estimate $0.81 $0.82 $3.34 $3.91
Low Estimate $0.68 $0.68 $3.25 $3.34
Prior Year $0.66 $0.75 $2.78 $3.28
Growth Rate (Year over Year) 13.97% 0.76% 18.05% 10.23%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Oct 09, 2015 | 7:22 AM EDT
LLY was upgraded from Neutral to Outperform, Credit Suisse said. $105 price target. Estimates also boosted, given higher expected Jardi...
This move in health care takes your breath away.
That's the saving grace where there is so much to dislike.
And right now, these stocks are mostly hated.
Eli Lilly has bucked the downtrend in other pharma names, and its chart is pointed higher.
Sep 18, 2015 | 6:58 AM EDT
Shares of LLY now seen reaching $115, according to Jefferies. Estimates also upped, as Jardiance/Glyxambi should drive near-term growth...

Eli Lilly Leaps to New Highs Real Money Pro($)

A very bullish setup could carry LLY much higher.
These three sectors hang in the balance of the FOMC's decision.
Today may be a good opportunity to exit some names.

Columnist Conversations

My bad - I must have misunderstood this part of the Diary. Maybe reword (just whenever you get the chance) to ...
All great questions. Firstly, unlike most I am not self confident. I take positons based on FMV analysis and p...
Doug - I noticed you have had a conviction towards the short side. First all-in short SPY (Oct 7 11:08 am), th...
Morgan Stanley's list to buy now into earnings season: ABBV, ALLY, AMZN, CCI, FIT, GOOGL, SABR, SBNY,VRTX, SA...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.